Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novel series of 5-HT1F agonists under study at Lilly

June 5, 1998

Lilly initiates clinical development of tomoxetine for ADHD

June 5, 1998

Unimed granted patent coverage for dronabinol use as dementia therapy

June 5, 1998

Milkhaus granted U.S. patent for amyloid plaque-reducing agent

June 5, 1998

Another group of CRF antagonists for stress-related disorders in development at Pfizer

June 4, 1998

Dopaminergic agents for schizophrenia described by AHP

June 4, 1998

Topiramate: clinical results in intractable epilepsy, preclinical neuroprotective effect

June 4, 1998

Minimum effective dose of licostinel determined in rat model of transient focal cerebral ischemia

June 4, 1998

Vertex receives notice of allowance for neurophilin compounds

June 4, 1998

ECE inhibitor prevents cerebral vasospasm in rabbits

June 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.